No adverse renal side effects in patients with mild to moderate renal dysfunction treated with Sofosbuvir

被引：1
|
作者：
Kuo, I. [1 ]
Roytman, M. [2 ]
Huddleston, L. [1 ]
Hong, L. [1 ]
Wan, I. H. [1 ]
Tsai, N. [1 ,2 ]
机构：
[1] Queens Liver Ctr, Honolulu, HI USA
[2] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31423-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-229
引用
收藏
页码：S511 / S511
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF NAPROXEN ON RENAL-FUNCTION IN OLDER PATIENTS WITH MILD TO MODERATE RENAL DYSFUNCTION
    SIMON, LS
    BASCH, CM
    YOUNG, DY
    ROBINSON, DR
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (03): : 163 - 168
  • [2] Exenatide pharmacokinetics in patients with mild to moderate renal dysfunction and end stage renal disease
    Linnebjerg, H
    Kothare, P
    Park, S
    Mace, K
    Reddy, S
    Vandeloise, E
    Mitchell, M
    Lins, R
    DIABETES, 2005, 54 : A116 - A116
  • [3] Clinical Features and Neurologic Severity in Stroke Patients with Mild to Moderate Renal Dysfunction
    Hoshino, Haruhiko
    Itoh, Yoshiaki
    Yamada, Satoshi
    Miyaki, Koichi
    Suzuki, Norihiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (05): : 343 - 349
  • [4] RENAL EFFECTS OF ORAL KETOROLAC IN PATIENTS WITH MILD-TO-MODERATE PAIN
    RAO, TRK
    NAIDU, MUR
    SHOBHA, JC
    RAVISEKHAR, K
    RANI, RU
    CHANDRASEKHAR, E
    CLINICAL DRUG INVESTIGATION, 1995, 9 (02) : 111 - 115
  • [5] Effects of fosinopril on renal function in patients with mild to moderate essential hypertension
    Zamboulis, C
    Karagiannis, A
    GotzamaniPsarrakou, A
    Deligianni, K
    Spyridonidis, T
    Fragos, S
    Psarrakos, K
    CLINICAL DRUG INVESTIGATION, 1996, 12 (05) : 251 - 258
  • [6] Mild/moderate renal dysfunction: its role in the preoperative evaluation
    Ramos, L. W.
    Nicoletti, L.
    Ignacio, F.
    Castilho, E.
    Elly, E.
    Cristina, B.
    Wolf, M.
    Calil, M.
    Goes, J. C. S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 758 - 758
  • [7] IMMUNORELATED RENAL ADVERSE EFFECTS IN PATIENTS TREATED WITH CHECKPOINT INHIBITORS
    Chandu Nanwani, Avinash
    Manuel Garcia, Jonay
    Perez Suarez, German
    Ramirez Puga, Ana
    Gonzalez Nuez, Selene
    Batista Garcia, Fatima
    Fernandez Granados, Saulo Jesus
    Esparza Martin, Noemi
    Garcia-Canton, Cesar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1090 - I1090
  • [8] Safety of Sofosbuvir-Based Regimens for the Treatment of Chronic HCV Infection in Patients with Mild or Moderate Renal Impairment
    Durand, Francois
    Pianko, Stephen
    Ni, Liyun
    De-Oertel, Shampa
    McNally, John
    Brainard, Diana M.
    McHutchison, John G.
    Schiff, Eugene R.
    Colombo, Massimo
    HEPATOLOGY, 2016, 64 : 428A - 428A
  • [9] DOXAZOSIN IN THE TREATMENT OF PATIENTS WITH MILD OR MODERATE HYPERTENSION AND MILD OR MODERATE RENAL-INSUFFICIENCY
    BARTELS, ACC
    DEVRIES, PMJM
    OE, LP
    VANBRONSWYK, H
    DONKER, AJM
    REVEILLAUD, RJ
    FILLASTRE, JP
    ZECH, P
    AMERICAN HEART JOURNAL, 1988, 116 (06) : 1772 - 1777
  • [10] Use of renal risk drugs in hospitalised patients with mild to moderate renal impairment
    Salvesen, Blix Hege
    Kirsten, Viktil
    Tron, Moger
    Aasmund, Reikvam
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 205 - 205
12345